ArticleFrontiers in microbiology2026
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Carbapenem-resistant Methods: Ninety-nine CRPA isolates were subjected to antimicrobial susceptibility testing, and 66 isolates were selected randomly for whole-genome sequencing. The Results: IMP-REL MIC values were available for the 99 non-duplicate CRPA isolates. Most isolates originated from respiratory specimens (51%), followed by body fluids (18%) and urine (10%). IMP-REL MICs ranged from 0.38 to 32 mg/L, with a median MIC of 1.5 mg/L and MIC₅₀/₉₀ values of 1.5 and 12 mg/L, respectively. Based on CLSI criteria, 78.8% of isolates were susceptible, 10.1% intermediate, and 11.1% resistant. MIC distributions demonstrated clustering at low concentrations with a distinct resistant tail. Weak but statistically significant positive rank-based correlations were observed between IMP-REL MICs and imipenem ( Conclusion: IMP-REL shows substantial
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.